COST-UTILITY ANALYSIS OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITOR SACUBITRIL/VALSARTAN COMPARED WITH ACE INHIBITORS FOR THE TREATMENT OF CHRONIC HEART FAILURE IN THE UNITED STATES

被引：0
|
作者：
Harrington, R. L. [1 ]
Zueger, P. M. [1 ]
Kumar, V. M. [1 ]
Rigoni, G. [1 ]
Atwood, A. M. [1 ]
DiDomenico, R. J. [1 ]
Touchette, D. R. [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.120
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV55
引用
收藏
页码：A49 / A49
页数：1
相关论文
共 50 条
  • [41] Estimated plasma volume in heart failure with reduced ejection fraction: ACE inhibitors versus angiotensin receptor/neprilysin inhibitor in follow up
    Varga, S.
    Antolkovic, L.
    Zeljkovic, I
    Pavlovic, N.
    Jordan, A.
    Pavlov, M.
    Vitlov, P.
    Rudan, D.
    Novak, A.
    Lisnjic, P.
    Manola, S.
    Jurin, I
    EUROPEAN HEART JOURNAL, 2024, 45
  • [42] Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Retrospective Multi-Institutional Study
    Hsiao, Fu-Chih
    Lin, Chia-Pin
    Yu, Chun-Chen
    Tung, Ying-Chang
    Chu, Pao-Hsien
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [43] Effectiveness and safety of angiotensin receptor-neprilysin inhibitor and sodium-glucose cotransporter-2 inhibitors for patients with heart failure with reduced ejection fraction: a meta-analysis
    Huang, Yun
    Fang, Chongbo
    Zhang, YuYu
    Ma, Lili
    Zhou, Hua
    Ye, Honghua
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (02) : 123 - 131
  • [44] Initial clinical experience with the first drug (sacubitril/valsartan) in a new class - angiotensin receptor neprilysin inhibitors in patients with heart failure with reduced left ventricular ejection fraction in Poland
    Kaluzna-Oleksy, Marta
    Kolasa, Jolanta
    Migaj, Jacek
    Pawlak, Agnieszka
    Lelonek, Malgorzata
    Nessler, Jadwiga
    Straburzynska-Migaj, Ewa
    KARDIOLOGIA POLSKA, 2018, 76 (02) : 381 - 387
  • [45] Real-World Prevalence of Adverse Events After Initiating Sacubitril/Valsartan Compared With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Systolic Heart Failure
    Adie, Sarah
    Bitar, Abbas
    Hanigan, Sarah
    Pogue, Kristen
    Koelling, Todd
    Dorsch, Michael
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (05) : 412 - 413
  • [46] Modification of the of the cardiometabolic profile using combined therapy of the angiotensin receptor-neprilysin inhibitor and empagliflozin in comorbid patients with Chronic Heart Failure and type 2 Diabetes Mellitus
    Tsygankova, O. V.
    Veretyuk, V. V.
    Mareyev, V. YU.
    KARDIOLOGIYA, 2020, 60 (05) : 146 - 152
  • [47] Comparative analysis of renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor and mineralocorticoid receptor antagonists in heart failure with mildly reduced ejection fraction
    Lin, T.
    Kuan, D. W. K.
    Lee, C. C. L.
    Wu, W. C. K.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [48] Successful Treatment of Severe Heart Failure in Advanced Diabetic Kidney Disease Using Angiotensin-neprilysin Inhibitors (Sacubitril/valsartan) - Report of Two Cases with Review of Options in Literature
    Jha, Ratan
    Mukku, Kiran K.
    Rakesh, Ambati K.
    Sinha, Sumeet
    INDIAN JOURNAL OF NEPHROLOGY, 2021, 31 (06) : 587 - 591
  • [49] Efficacy and safety of sacubitril valsartan in heart failure compared to renin angiotensin adosterone system inhibitors: a systematic review and meta analysis of randomised controlled trials
    Hernandez, A. V.
    Pasupuleti, V.
    Scarpelli, N.
    Malespini, J.
    Banach, M.
    Bielecka-Dabrowa, A. M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 954 - 954
  • [50] Comparative analysis of mineralocorticoid receptor antagonists and renin-angiotensin system inhibitors/angiotensin receptor neprilysin inhibitor in heart failure with mildly reduced ejection fraction
    Lee, Chia-Chen
    Kuan, David Te-Wei
    Chang, Kai-Chun
    Chen, Zheng-Wei
    Cheng, Jen-Fang
    Lin, Ting-Tse
    Lin, Lian-Yu
    Wu, Cho-Kai
    FRONTIERS IN PHARMACOLOGY, 2024, 15
12345